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Executive Summary 
The Government of India has committed to increasing modern contraceptive use from 47.7 percent (IIPS 
and ICF 2017) to 54.3 percent among married women aged 15-49 by 2020 (FP2020 and Government of India 
2017). To achieve this goal, India has committed to increase access, choice, and quality of family planning 
(FP) services by focusing on modern reversible methods. Among married women using a modern 
contraceptive method, 75 percent use female sterilization, 12 percent use condoms, 9 percent use oral 
contraceptive pills, 3 percent use IUDs, one percent use male sterilization, and 0.4 percent use injectables 
(IIPS and ICF 2017). Discontinuation rates for modern reversible methods are high, with 44 percent of 
episodes of modern reversible method use discontinued within the first year (IIPS and ICF 2017).  
To better understand the dynamics of reversible modern contraceptive use in India, The Evidence Project, 
led by the Population Council with support from the United States Agency for International Development 
(USAID)/India, conducted a prospective cohort study of married women in India who initiated a reversible 
modern contraceptive method. The objectives of the study were to:  
 Explore one-year contraceptive use dynamics among a cohort of modern reversible contraceptive 
users by modern method (oral contraceptive pill, IUD, injectable). 
 Understand the reasons for discontinuation of modern reversible contraceptive methods. 
 Examine the experience of side effects of modern reversible contraceptive users.  
 Assess the quality of care received by clients at time of method adoption. 
 Understand experiences using and obtaining contraceptive methods over the course of 12 months. 
The study enrolled a cohort of 2,699 married women aged 15-49 who initiated a new episode of using a 
reversible contraceptive method: postpartum intrauterine device (PPIUD), interval IUD, injectable 
contraceptive, or oral contraceptive pill (OCP). New episodes of use included women who had never used a 
method before and those that had previously used a method but were not using at the time of study 
enrollment. Women were interviewed in-person at four time points: within one month of initiating the 
method (enrollment), and 3, 6, and 12 months later. The study was conducted in Haryana and Odisha states, 
and women were enrolled primarily at government and non-governmental organization (NGO) facilities and 
through accredited social health activists (ASHAs) at the community level. Respondents were purposively 
sampled; therefore, proportions are not representative at the state level or representative of method-specific 
family planning users. The study was reviewed and approved by the ethics committee of the Government of 
Odisha and by the Institutional Review Board of the Population Council. All women enrolled into the study 
gave written consent for voluntary participation in the study before enrollment and before all follow-up 
interviews.  
Of the 2,699 women enrolled into the study, 412 began using the PPIUD at enrollment, 640 began using the 
interval IUD, 581 began using the injectable, and 1,066 began using OCPs. At enrollment, 71 percent of the 
women were between 20 and 29 years old, 84 percent were Hindu, 51 percent had secondary or higher levels 
of education, and 99 percent had at least one child. Fifty-nine percent did not want to have any more children 
in the future at the time of the enrollment interview. Fifty-two percent had used a modern method of 
contraception in the past. Key findings of the study included: 
Across four domains of quality of care (respectful care, information exchange to enable appropriate method 
selection, effective use of method selected, and continuity of contraceptive use and care), PPIUD users 
consistently reported receiving lower levels of quality of care than users of other methods. At enrollment, 38 
percent of OCP users, 38 percent of interval IUD users, 35 percent of injectable users, and 17 percent of 
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PPIUD users reported receiving the Method Information Index Plus (MIIplus), meaning they answered “yes” 
to four questions: 1) Were you told about other methods, 2) Were you told about potential side effects of the 
method you selected, 3) Were you told what to do if you experience side effects/problems with the method 
you selected, and 4) Were you told about the possibility of switching methods if the method you selected was 
not suitable? Among users of the PPIUD, interval IUD, and OCP, receipt of the MIIplus increased with 
wealth tertile. 
Implications: Quality of care should be improved for users of all modern methods of family 
planning, and especially for PPIUD users and women of lower wealth status. Quality of care 
improvement efforts should also be routinely monitored and tracked to ensure that women are 
receiving high quality services. Providers of all cadres should be trained on respectful care, and 
information exchange on appropriate method selection, effective use of methods, and continuity 
of contraceptive use and care. 
Over the course of 12 months, 23 percent of women (n=2,559) reported experiencing side effects of their 
enrollment method, including 50 percent of injectable users, 22 percent of PPIUD users, 22 percent of 
interval IUD users, and 11 percent of OCP users. Eighteen percent of women reported talking to someone 
about side effects, and 12 percent talked to their provider/ASHA about the side effects they experienced. 
Common side effects experienced were abdominal cramping/pain among PPIUD users (10%) and interval 
IUD users (13%); heavy menstruation among PPIUD users (9%) and injectable users (12%); and absence of 
menstruation among injectable users (25%).  
Among women who discontinued the enrollment method (n=921) at some point during the study, 24 percent 
did so because of side effects experienced or health concerns. An additional 20 percent reported not 
menstruating since starting the method as the reason why they discontinued the method. Not menstruating 
was the most common reason why women who initiated the injectable stopped using the method. Twelve 
percent discontinued because they wanted to become pregnant, and 10 percent discontinued because their 
husband was not living at home, suggesting these women no longer had a need for family planning.  
Implications: Most women (77%) did not report experiencing side effects of their enrollment 
method, though many who discontinued the enrollment method did so due to side effects or other 
health concerns. Contraceptive initiators should receive follow-up visits from frontline health 
workers to provide support and answer questions related to the method selected. These visits 
could assist women with information on managing side effects or switching to a different method. 
While most women—61 percent—continued to use the method they adopted at enrollment throughout the 
year, considerable movement among contraceptive use states was observed, including switching to different 
FP methods, continuing use of the switched methods, or discontinuing contraceptive use altogether. Interval 
IUD (74%) and OCP (75%) users were most likely to continue to use these methods they began at 
enrollment, followed by PPIUD users (66%). Less than half (44%) of injectable users continued to use 
injectables. Overall, discontinuation of all contraception was low, at 13 percent. However, half of those not 
using any method did not want to have any more children in the future, 7 percent wanted to wait more than 
two years, and 12 percent didn’t know. These women, a total of 69 percent of non-users, therefore had an 
unmet need for contraception at the end of one year. These findings highlight the importance of providers 
and ASHAs offering continuous support to women who want to delay or prevent pregnancy that includes 
opportunities to switch methods as their fertility desires change over time. Information and FP methods 
offered to women at the initial FP visit alone is not enough to ensure that women continuously meet their 
needs for voluntary contraceptive use; continuous follow-up is needed. 
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Implications: Discontinuation of contraceptive use altogether after one year was relatively low. 
There was considerable movement between various states of contraceptive use. Women did 
switch to other methods, both modern as well as traditional methods. Among those who were not 
using at 12 months, however, the majority had an unmet need for family planning. At the time of 
method adoption and after the initial visit, it is important to continue to offer women information 
about the possibility of switching to other methods, including modern fertility awareness-based 
methods.  
At enrollment, most women wanted to use their family planning method for limiting (59%) or delaying 
childbearing for at least two years (28%). While these preferences appeared to be relatively stable over time, 
there were substantial variations in fertility preferences over the course of the study at the individual level. For 
example, when examining the data longitudinally, over one-third (35%) of women who did not want to have 
any children at enrollment changed their mind and reported wanting to have more children in at least one 
follow-up interview. Additionally, a significant proportion didn’t know whether or when they wanted to have 
another child in at least one interview, as 6 percent of respondents at enrollment and 15 percent after one 
year were unsure. Being unsure of fertility preferences is a legitimate response that may change over time, and 
providers and ASHAs should be sure to ask women about their fertility preferences at each interaction. When 
asking women about their fertility desires, a better understanding of their motivations to prevent pregnancy 
and under what circumstances they may change their mind may help providers support women in selecting 
appropriate methods.  
Implications: These data show that while fertility intentions appear to remain relatively 
consistent over a year, women’s desires can and do change. Asking women about their fertility 
intentions and motivation to prevent pregnancy routinely in FP counseling can help ensure that 
women are selecting methods that best meet their changing reproductive needs.  
After one year, 62 percent of respondents did not want to have any more children. While those using modern 
methods after one year were most likely to report not wanting to have any more children (64%), over half of 
those using traditional methods (56%) and half of those not using any method (50%) did not want any more 
children either. These women would be potential candidates for modern methods of contraception and 
should be supported in switching to a different modern method according to their reproductive needs. Since 
such a large proportion of modern, traditional, and non-users of family planning desired no more children, 
and since this was the strongest fertility preference among this sample of women, there is a rationale to 
continue supporting the female sterilization program in India. Coupled with counseling about fertility 
preferences and motivation to prevent pregnancy, this could help enable women in India with an unmet need 
for FP for limiting births to meet their reproductive intentions. 
Implications: India should continue to expand the basket of methods available to women while 
supporting sterilization as part of the national family planning program. 
Seven percent of women experienced a pregnancy at some point during the study (including women who 
were using and not using a contraceptive method at the time they became pregnant). Of the 183 women who 
experienced a pregnancy during the study period, half (51%) did not want to become pregnant at all, did not 
want to become pregnant at that time, or didn’t know. Less than 10 percent of women who experienced a 
pregnancy terminated the pregnancy.  
Implications: As half of pregnancies experienced in this study were not wanted at all or at that 
time, there is a need to ensure that women are offered an array of methods to switch to in order to 
prevent unwanted pregnancies.   
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Introduction 
Use of modern contraceptive methods in India has steadily increased from 37 percent among married women 
aged 15-49 in 1992-93 (IIPS 1995) to 48 percent in 2015-16 (IIPS and ICF 2017). At the London Summit on 
Family Planning in 2017, the Government of India articulated a commitment to increase modern 
contraceptive use to 54.3 percent among married women of reproductive age by increasing access, choice, 
and quality of family planning (FP) services (FP2020 and Government of India 2017). As part of its FP2020 
commitment, India aims to expand method choice available to women by focusing on modern reversible 
methods, including the intrauterine contraceptive device (IUD) and postpartum IUD (PPIUD).  
Currently, the method mix in India is heavily skewed toward female sterilization. It is used by 75 percent of 
married women who are using a modern contraceptive method (IIPS and ICF 2017). Other methods used 
include condoms (12%), oral contraceptive pills (OCPs) (9%), IUD (3%), male sterilization (1%), and 
injectables (0.4%). Discontinuation rates for these reversible methods, however, remain high, as 44 percent of 
episodes of use of all modern reversible methods are discontinued within one year (IIPS and ICF 2017). One-
year discontinuation rates are highest for injectables (51%), followed by condoms (47%), OCPs (42%), and 
the IUD (26%). While 12 percent discontinued because they wanted to have a child, only in 6 percent of 
discontinued episodes did the woman switch to a different FP method (IIPS and ICF 2017), suggesting that 
most women who discontinue may continue to have a need for family planning.  
To enable India to meet its FP2020 goals and design programs that meet the needs of women and their 
families, a better understanding of contraceptive use dynamics, including contraceptive choice, 
discontinuation, and switching behaviors, is paramount. To fill this gap in the literature, The Evidence 
Project, led by the Population Council and funded by the United States Agency for International 
Development (USAID)/India, conducted a prospective cohort study of married women in India who 
initiated a reversible contraceptive method. Most research to date on contraceptive use dynamics has been on 
contraceptive use retrospectively. For example, the Demographic and Health Surveys (DHS) ask women to 
recall all episodes of contraceptive use and reasons for discontinuing those episodes in the 3-59 months prior 
to the interview (IIPS and ICF 2017). Asking women their reasons for discontinuing a method that may have 
occurred five years ago introduces the possibility of recall bias. The present study, on the other hand, was 
conducted prospectively over the course of one year, reducing the potential for recall bias. Additionally, this 
study has focused on less understood aspects of contraceptive use dynamics, including the experience of side 
effects and their effect on daily life, quality of care received by clients at the time of method adoption, and 
factors that enable method switching among modern contraceptive methods if the current method is not 
suitable.  
This report summarizes the results of the prospective cohort study on the dynamics of reversible method use. 
The findings can be used to inform India’s national family planning program as the government focuses on 
increasing access, choice, and quality of FP services with an emphasis on reversible methods.   
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Objectives 
The objectives of this report are to: 
 Explore one-year contraceptive use dynamics among a cohort of modern reversible contraceptive 
users by modern method (oral contraceptive pill, IUD, injectable). 
 Understand the reasons for discontinuation of modern reversible contraceptive methods. 
 Examine the experience of side effects of modern reversible contraceptive users.  
 Assess the quality of care received by clients at time of method adoption. 
 Understand experiences using and obtaining contraceptive methods over the course of 12 months.  
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Methods 
Study design, enrollment, and sampling 
A cohort of 2,699 married women aged 15-49 who initiated a 
new episode of using a reversible contraceptive method: 
postpartum intrauterine device (PPIUD), interval IUD, 
injectable contraceptive, or oral contraceptive pill (OCP), was 
followed for one year. A new episode of use included women 
who had never used a modern method of family planning 
previously as well as those who had used a modern method at 
some point in the past but had not been using a modern 
method just prior to study enrollment.  
Women enrolled in the study were interviewed at four time 
points: within one month of initiating the method 
(enrollment), and 3, 6, and 12 months later. The study was 
conducted in nine districts of two Indian states (Figure 1)—
Nuh, Panipat, Rewari, and Sonipat districts of Haryana and 
Baleswar, Bhadrak, Kendujhar, Khorda, and Mayurbhanj 
districts of Odisha. Women were enrolled from December 
2016 to October 2017.  
In Haryana, women were enrolled through accredited social 
health activists (ASHAs) at the community level. Districts in 
which a private organization was implementing an injectable program and where health management 
information systems reported a high number of IUDs inserted in the last year were selected for inclusion in 
the study, as there was a higher likelihood of identifying modern reversible method users. ASHAs in these 
districts identified women who adopted a modern reversible method within the preceding month and asked 
their permission to bring a member of the research team to their home. In Odisha, PPIUD users were 
primarily enrolled at select government health facilities from delivery wards, though some were enrolled via 
ASHAs identified by the facilities. Interval IUD and OCP users were enrolled primarily through ASHAs 
identified by facility managers, and injectable users were enrolled primarily at non-governmental organization 
(NGO) facilities. Women in this study were sampled purposively. Proportions presented in this report are 
limited to the sampled population only and are not to be interpreted as representative of method-specific 
family planning users. In addition, while combined results are presented for all women surveyed in this study, 
estimates are not representative at the state or district levels.  
All interviews were conducted in-person. In both states, women enrolled at facilities were interviewed at the 
facility upon being approached by the research team and providing informed consent. Women who were 
enrolled through ASHAs gave their consent to the ASHA to be contacted by the research team. The research 
team then contacted the women to determine a location for the interview, either at home or at the facility, per 
the respondent’s preference. Follow-up interviews were also conducted in-person, either at home or at the 
facility. Women who were not reachable at the 3-month or 6-month interview could reenter the study at a 
later interview time. Of 2,699 women interviewed at enrollment, 2,306 were re-interviewed 3 months later, 
2,396 6 months later, and 2,441 12 months later, resulting in a follow-up rate of 85.4 – 90.4 percent for the 
year (Table 1). 
  
FIGURE 1. STUDY IMPLEMENTATION 
SITES 
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TABLE 1. PROPORTION OF ENROLLED RESPONDENTS INTERVIEWED AT EACH 
TIME-POINT, BY ENROLLMENT METHOD 
 Enrollment Month 3 Month 6 Month 12 
 n n % n % n % 
PPIUD  412 327 79.4 344 83.5 358 86.9 
Interval IUD  640 545 85.2 556 86.9 564 88.1 
Injectable  581 455 78.3 495 85.2 510 87.8 
OCP  1,066 979 91.8 1,001 93.9 1,009 94.7 
Combined 2,699 2,306 85.4 2,396 88.8 2,441 90.4 
Data collection 
Data collector training 
One study coordinator and five female data collectors were hired in each state. Study coordinators managed 
all data collection activities, and female data collectors enrolled all participants and conducted all interviews. 
Study coordinators were trained in New Delhi on the study objectives, study instruments, and data collection 
using a computer-assisted personal interviewing (CAPI) package. Intensive, one-week trainings of data 
collectors were conducted in each state by the research team and respective study coordinator. Trainings 
covered the study objectives and purpose, a review of each question and its purpose, a review of informed 
consent forms, use of data collection software and CAPI package, and data management including data flow 
and file backup. The training also specifically focused on the ethical aspects of the study, including the 
meaning and process of informed consent, the importance of protecting the privacy of respondents, and 
confidentiality of the information obtained from respondents. Three-day trainings were conducted prior to 
each follow-up interview to refresh data collectors’ knowledge and orient them to the new questionnaires. 
Data collection 
Female data collectors interviewed respondents face-to-face at four time points using mini-laptops. The CAPI 
package was developed in Hindi and Odia, the local languages of Haryana and Odisha. Informed consent was 
obtained prior to the enrollment interview and each of the three follow-up interviews. 
At enrollment, data collectors asked respondents about a range of information including demographic data, 
fertility intentions, previous contraceptive use, birth history, counseling received at the time of method 
initiation, satisfaction with this visit, contact with frontline health workers, knowledge of contraceptive 
methods, reproductive autonomy, household decision making, empowerment, attitudes toward domestic 
violence, and couple’s communication about sex. At follow-up interviews, respondents provided information 
on changes in family structure and employment, fertility intentions, current contraceptive use, experiences 
and management of side effects (if experienced), experiences obtaining OCP and injectable doses, and follow-
up services for IUD. For those who discontinued, additional questions were asked about reasons for 
discontinuation, whom the respondents spoke to about the desire to discontinue, counseling received for 
respondents who switched to a new method, and, for those who did not switch to a new method, their 
intention to use a contraceptive in the future. 
Data management and analysis 
Data collection supervisors collated the data and sent it to the research team in New Delhi, India, where the 
data were carefully reviewed for errors. The research team routinely checked for inconsistencies and cleaned 
the data when possible throughout the study period. Respondents were given unique identifiers to enable 
them to be linked for follow-up interviews, and these unique identifiers were known only to the research 
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team and stored in a password-protected computer. The text responses for “others (specify)” were examined 
and recoded.  
Descriptive statistics and bivariate analyses by enrollment method were conducted. Data analysis was 
conducted by enrollment method because strategies for enrollment were different for each method. Chi-
square tests were used to determine significant differences in experiencing pregnancy by enrollment method 
and in receiving the MIIplus (Method Information Index Plus) by respondent characteristics.  
Ethical review 
The study was reviewed and approved by the ethics committee of the Government of Odisha and by the 
Institutional Review Board of Population Council. All respondents gave written consent for voluntary 
participation in the study before the enrollment interview and before each of the three follow-up interviews. 
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Results 
The results section of this report presents an overview of the characteristics of the women enrolled in the 
study, their experiences with the enrollment method, including quality of care at the time of method 
adoption, experiences of side effects, and reasons for discontinuation of the enrollment method. The report 
then presents women’s contraceptive use dynamics after one year, including changes in contraceptive use, 
fertility preferences, experiences using and obtaining contraceptive methods, and experiences of pregnancy 
during the 12-month period.  
Respondent characteristics  
Table 2 shows the demographic characteristics of respondents at enrollment by method initiated. Most 
women enrolled into the study were between 20 and 29 years old (71%) and Hindu (84%). Overall, 38 
percent of the women belonged to marginalized communities, i.e., scheduled castes and scheduled tribes. 
Twenty-three percent of women had never attended school, while just over half (51%) had secondary levels 
of education or higher. Most were housewives (94%), though a small proportion were manual laborers (2%), 
worked in white collar jobs (1.9%), or were farmers (1.5%).  
Forty-one percent of women had one child at the time of enrollment while one-third (33%) had two children 
and one-quarter (25%) had three or more. Less than one percent did not have any living children (0.7%). At 
enrollment, three in five women (59%) did not want to have any more children in the future, 6 percent 
wanted to have a child within two years, and just over one-quarter (28%) wanted to have a child in more than 
two years. Seven percent didn’t know or were undecided about when they wanted to have a child. Over half 
of the women had used a modern method of contraception in the past (52%). Twelve percent had used only 
traditional methods1 previously, while over one-third (36%) had previously never used a contraceptive 
method.  
Nearly half of respondents (49%) had obtained their current method from public health facilities, while 33 
percent obtained it from a frontline health worker, 13 percent from an NGO, 3 percent from a medical store, 
and 3 percent from a private facility. Public health facilities include district hospitals, community health 
centers, primary health centers, and sub-centers. Frontline health workers include accredited social health 
activists (ASHAs), Anganwadi workers (AWW), and auxiliary nurse midwives (ANM). ANMs are permitted 
to insert IUDs in India and are based at primary health centers and sub-centers (Scott et al. 2014). Thus, while 
some PPIUD and IUD users received their IUD from an ANM, they are counted as receiving their IUD 
from a public health facility, as the IUD is not provided via community-based distribution. Additionally, while 
11 percent of injectable users and 2 percent of OCP users obtained their injection from a medical store, they 
received counseling and a referral for their method from a provider or frontline health worker. NGO facilities 
are distinguished from commercial private facilities as they are within the non-profit sector.  
  
 
1 Traditional methods include withdrawal, abstinence, and rhythm method. 
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TABLE 2. RESPONDENT CHARACTERISTICS BY ENROLLMENT METHOD (N=2,699) 
 Enrollment Method  
Background characteristics 
PPIUD 
(n=412) 
Interval IUD 
(n=640) 
Injectable 
(n=581) 
OCP 
(n=1,066) 
Combined 
(n=2,699) 
Age group in years      
   Below 20 years 5.6 8.4 0.7 1.3 3.5 
   20-24 years 58.5 41.1 20.3 32.7 36.0 
   25-29 years 27.7 30.8 36.7 38.6 34.6 
   30-34 years 7.3 13.3 22.0 18.0 16.1 
   35 years and above 1.0 6.4 20.3 9.4 9.7 
Religion      
   Hindu 97.3 92.5 67.5 83.2 84.2 
   Muslim 1.9 7.2 32.2 16.6 15.5 
   Other 0.7 0.3 0.3 0.2 0.3 
Caste/tribe      
   Scheduled caste 15.5 13.8 13.4 23.4 17.7 
   Scheduled tribe 33.7 31.7 5.7 16.0 20.2 
   Other backward class 19.4 28.4 30.1 29.1 27.7 
   General 30.3 23.0 41.1 29.0 30.4 
   Other 1.0 3.1 9.6 2.6 4.0 
Education      
   No education 16.8 23.6 30.3 20.9 22.9 
   Primary 16.0 9.2 10.5 12.7 11.9 
   Middle 16.3 13.3 13.1 14.8 14.3 
   Secondary 35.9 25.2 24.6 32.8 29.7 
   Higher secondary 9.5 17.3 9.6 11.3 12.1 
   Above higher secondary 5.6 11.4 11.9 7.5 9.1 
Employment      
   Housewife 92.2 91.9 93.6 95.4 93.7 
   Business 0.5 0.6 0.7 0.8 0.7 
   Farmer 1.5 4.8 0.2 0.3 1.5 
   Manual labor 4.9 1.1 2.4 1.6 2.1 
   White collar jobs 1.0 1.6 3.1 1.9 1.9 
Parity^      
   No children 0.7 0.3 0.3 1.1 0.7 
   1 child 59.7 38.9 25.5 44.6 41.4 
   2 children 31.1 36.9 38.4 28.6 33.0 
   3+ children 8.3 23.7 35.8 25.7 24.7 
Fertility preferences      
   Did not want any more children 43.7 61.6 78.0 53.0 59.0 
   Desired within the next year 0.0 1.3 0.5 1.8 1.1 
   Desired within 1 to 2 years 2.7 3.3 5.9 7.5 5.4 
   Desired after more than 2 years 49.3 26.9 12.1 28.7 27.8 
   Did not know when 4.4 7.0 3.6 9.0 6.7 
Previous contraceptive use      
   Modern method 31.1 49.5 64.0 55.6 52.2 
   Traditional methods only  11.4 13.9 9.0 11.3 11.5 
   No previous contraceptive use 57.5 36.6 27.0 33.1 36.3 
Current method source      
   Public health facility 100 90.5 37.4 10.5 48.9 
   Frontline health worker 0.0 0.0 1.7 82.0 32.8 
   Medical store 0.0 0.0 11.4 1.3 3.0 
   Private facility 0.0 6.3 3.8 0.8 2.6 
   NGO 0.0 3.3 45.8 5.4 12.8 
^Percentages may not add to 100% due to missing values   
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Quality of care received at enrollment 
At enrollment into the study, all women were asked about the quality of care they received during their visit 
with a provider or a frontline health worker to obtain their family planning method. Though 3 percent 
obtained their method (injectable or OCP) from a medical store, the counseling for the method was done by 
a provider at a public facility or by a frontline health worker. This study did not observe providers during the 
family planning counseling interactions, but rather captured the care and information received as reported by 
clients after the interaction. Clients were interviewed within one month of receiving their enrollment method, 
in efforts to minimize recall bias.  
Measures of quality were broken down into four domains of process quality (Jain, Townsend & Ramarao 
2018; Jain et al. 2019a):  
1) Respectful care relates to interpersonal interactions between provider and client and assesses 
aspects of privacy and confidentiality. 
2) Method selection focuses on exchange of information between a provider and client to enable 
selection of an appropriate method.  
3) Effective use of the selected method includes information given to the client about the selected 
method.  
4) Continuity of contraceptive use and care covers information on follow-up appointments and the 
ability to switch methods or sources of family planning.  
 
Figure 2 presents aspects of respectful care received by women when they initiated the enrollment method. 
Nearly all women reported they were treated well by the provider (99-100%), regardless of method received. 
For other indicators, a greater proportion of injectable and OCP users reported receiving respectful care 
compared to interval IUD and PPIUD users. For example, 97 and 99 percent of OCP and injectable users, 
respectively, reported that their questions were answered to their satisfaction, while this was reported by 86 
percent of interval IUD and 70 percent of PPIUD users. Eighty-two percent of injectable and OCP users felt 
they had visual privacy during their counseling session, compared to 68 percent of IUD and 53 percent of 
PPIUD users.  
 
FIGURE 2. RESPECTFUL CARE AT INITIAL VISIT BY ENROLLMENT METHOD  
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Figure 3 presents women’s reporting of information received and questions asked by the provider that would 
enable appropriate method selection. Fewer PPIUD users reported being asked about or receiving 
information for method selection compared to interval IUD, injectable, or OCP users. Eighty-six percent of 
OCP and injectable users and 73 percent of interval IUD users reported being asked about their preferred FP 
method compared to only 31 percent of PPIUD users. Less than half of all users received information about 
methods that protect against STIs or HIV (10% of PPIUD users, 40% of injectable and OCP users, and 47% 
of interval IUD users) or received information without any one method being promoted (29% of PPIUD and 
OCP users, 32% of interval IUD users, and 38% of injectable users).  
 
FIGURE 3. METHOD SELECTION AT INITIAL VISIT BY ENROLLMENT METHOD 
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Women were asked about the information that they were given about effective use of the method that they 
selected at enrollment (Figure 4). While only 53 percent of PPIUD users were told how to use the selected 
method, 85 percent of IUD, 92 percent of injectable, and 97 percent of OCP users reported receiving this 
information. Most women reported that they were told how their chosen method works: 66 percent of 
PPIUD users, 67 percent of injectable users, 79 percent of IUD users, and 91 percent of OCP users. Fewer 
women, however, reported that they were told about method-related side effects (27% of PPIUD, 47% of 
interval IUD, 48% of OCP, and 58% of injectable users), how to manage side effects/problems (25% of 
PPIUD, 44% of OCP, 45% of interval IUD, and 45% of injectable users), and the warning signs (severe 
adverse effects) associated with the method selected (27% of PPIUD, 33% of OCP, 43% of injectable, and 
45% of interval IUD users).  
 
FIGURE 4. EFFECTIVE USE OF SELECTED METHOD AT INITIAL VISIT BY 
ENROLLMENT METHOD 
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Figure 5 presents the final domain of quality of care: clients’ reports of information given to enable continuity 
of contraceptive use and care. More PPIUD (74%), interval IUD (81%), and injectable users (81%) were told 
about the timing of their next visit compared to OCP users (47%). Being told about the possibility of 
switching methods if current method was not suitable ranged from a low of 41 percent among PPIUD users 
to 71 percent of interval IUD users. The percentage of women who were told about other sources of 
contraceptive supply ranged from 41 percent of PPIUD users to 70 percent of OCP users. Seventy-five 
percent of injectable users, 50 percent of interval IUD users, and 36 percent of PPIUD users were given an 
appointment card for their next visit. Few OCP users (9%) were given an appointment card.  
 
FIGURE 5. CONTINUITY OF CONTRACEPTIVE USE AND CARE AT INITIAL VISIT BY 
ENROLLMENT METHOD  
 
  
41
41
74
36
58
71
81
50
45
64
81
75
70
62
47
9
0 25 50 75 100
Percent
PPIUD (n=412) Interval IUD (n=640) Injectables (n=581) OCP (n=1,066)
Told about possibility of switching
the method if selected method was 
not suitable
Told about other sources of FP 
supply
Told about timing of next visit
Given appointment card for follow-up 
visit
 THE EVIDENCE PROJECT | 15 
Method Information Index Plus (MIIplus) 
The Method Information Index (MII) is a core indicator that FP2020 uses to track progress towards 
achieving 120 million additional users of contraceptives by 2020. It is an indicator of informed choice and 
consists of three questions: 1) Were you told about other methods, 2) Were you told about potential side 
effects of the method you selected, and 3) Were you told what to do if you experience side effects? Women 
who answered “yes” to all three are considered to have received full information of the MII.  
As shown elsewhere using data from this study (Jain et al. 2019b), adding a fourth question to the MII about 
the possibility of switching methods if the method selected was no longer suitable better predicts 
contraceptive continuation three months later. This new measure, the MIIplus, is calculated as the percentage 
of women who answer “yes” to all four questions. Overall, few women reported receiving all four 
components of the MIIplus. Among PPIUD users, 17 percent reported receiving MIIplus. More than one-
third of injectable (35%), interval IUD (38%), and OCP (38%) users reported receiving all four components 
of the MIIplus (data not shown).  
Figure 6 presents women’s receipt of the MIIplus by women’s characteristics of age, parity, education, and 
previous modern method use. There were no significant differences by age of women in reported receipt of 
the MIIplus for users of any method. Reported receipt of the MIIplus varied by education level for PPIUD 
and OCP users. PPIUD users and OCP users who had secondary or higher levels of education were more 
likely to report receiving complete MIIplus. In addition, there was a significant difference in women who 
reporting receiving MIIplus by parity for interval IUD and OCP users. Among interval IUD users, receipt of 
MIIplus was lowest for those with none or one child, at 33 percent, compared to 43 percent among those 
with three or more children. OCP users with two children were least likely to report receiving MIIplus, at 32 
percent, compared to 43 percent of those with at least three children. Previous modern method use 
influenced the MIIplus information received for interval IUD (46%), injectable (40%), and OCP (49%) users. 
Receipt of the MIIplus was significantly different by wealth tertile for users of PPIUD (5% of those in the 
lowest tertile compared to 24% in the highest), interval IUD (24% in the lowest tertile compared to 53% in 
the highest), and OCP users (20% in the lowest and 59% in the highest). For injectable and OCP users, 
receipt of the MIIplus was less likely for those in rural areas (30% of injectable and 36% of OCP) than those 
in urban areas (42% of injectable and 49% of OCP users).  
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FIGURE 6. RECEIPT OF COMPLETE INFORMATION ON THE MIIPLUS AT 
ENROLLMENT, BY METHOD AND RESPONDENT CHARACTERISTICS  
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Experiences of side effects on enrollment method 
Women who completed at least one follow-up interview (n=2,559) were asked whether they had experienced 
side effects while using the enrollment method. This included women who had continued using the 
enrollment method, discontinued it, or switched to a different method at any follow-up interview. Those who 
continued using the enrollment method throughout the study were asked about side effects of that method at 
each follow-up interview. Women who discontinued were asked about their side effects of the discontinued 
enrollment method at the first follow-up interview after discontinuation.  
Table 3 presents women’s experiences of side effects. Throughout the 12-month study period, 23 percent of 
respondents experienced side effects while using their enrollment method. Half of injectable users (50%) 
reported experiencing side effects of the method. Lower proportions of PPIUD (22%) and interval IUD 
(22%) users reported experiencing side effects. Eleven percent of OCP users reported experiencing side 
effects of the method.  
Among all contraceptive users, the three most commonly reported side effects were heavy bleeding (6%), 
abdominal pain/cramping (6%), and no bleeding (6%). For method-specific side effects, 25 percent of 
injectable users reported no bleeding as a side effect of the method. For PPIUD (10%) and IUD (13%) users, 
abdominal pain/cramping was the most common side effect, while weakness and dizziness (4% each) were 
the most common for OCP users.  
TABLE 3. EXPERIENCES OF SIDE EFFECTS ON ENROLLMENT METHOD, BY 
ENROLLMENT METHOD 
 Enrollment Method  
 
PPIUD 
(n=376) 
Interval IUD 
(n=620) 
Injectable 
(n=531) 
OCP 
(n=1,032) 
Combined 
(n=2,559) 
Experienced side effects on 
enrollment method 
22.3 21.8 49.7 10.8 23.2 
Side effects experienced†      
   Heavy bleeding 8.8 4.8 12.2 1.5 5.6 
   Abdominal pain/cramping 10.4 12.6 3.0 1.0 5.6 
   No bleeding 0.5 0.5 25.1 0.2 5.5 
   Weakness 4.0 2.7 4.5 3.9 3.8 
   Dizziness 2.1 1.9 3.8 4.2 3.2 
   Little bleeding 1.3 1.8 9.2 0.7 2.8 
   Backache 1.3 4.4 2.3 0.1 1.8 
   Irregular menstruation 0.3 0.7 5.8 0.5 1.6 
   Nausea 0.5 0.7 1.3 1.9 1.3 
   Headache 0.8 0.7 1.7 1.0 1.0 
   Weight gain 0.0 0.0 3.8 0.5 1.0 
   Swollen feet 0.5 0.2 1.5 0.8 0.7 
   Vomiting 0.3 0.5 0.8 1.0 0.7 
   Vaginal discharge 2.9 0.8 0.2 0.1 0.7 
   Weight loss 0.3 0.3 1.9 0.1 0.6 
   Spotting 0.3 0.3 1.9 0.0 0.5 
   Vaginal itch 0.8 0.7 0.8 0.0 0.4 
   Breast pain, tenderness, or 
swelling 
0.0 0.3 0.4 0.2 0.2 
   Vaginal inflammation 0.3 0.5 0.0 0.0 0.2 
   Fever 0.0 0.2 0.6 0.0 0.2 
   High blood pressure 0.0 0.2 0.0 0.0 0.0 
   Low blood pressure 0.0 0.0 0.0 0.1 0.0 
   Other  0.5 0.7 3.4 0.5 1.1 
   Don't know 1.1 0.0 1.7 0.2 0.6 
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† Multiple responses possible 
On average, across all methods initiated at enrollment, 18 percent of women reported talking to somebody 
about side effects experienced (Table 4). Twelve percent reported talking to a provider or ASHA about their 
side effects and nearly all of those (11% of total) reported returning to the same provider/ASHA or facility to 
discuss side effects. Speaking to a provider or ASHA about side effects varied by method ranging from a high 
of 25 percent among injectable users to a low of 6 percent among OCP users.  
 
TABLE 4. REACTIONS TO SIDE EFFECTS OF ENROLLMENT METHOD AMONG 
WOMEN WHO EXPERIENCED SIDE EFFECTS, BY ENROLLMENT METHOD 
 Enrollment method  
 PPIUD 
(n=376) 
Interval IUD 
(n=620) 
Injectable 
(n=531) 
OCP 
(n=1,032) 
Combined 
(n=2,559) 
Talked to somebody about 
experiencing side effects 16.5 17.1 39.2 7.7 17.8 
Talked to a provider or ASHA 
about side effects 9.8 11.8 24.9 5.9 11.8 
Returned to same 
provider/ASHA or facility to 
discuss side effects 
9.6 11.3 22.8 5.5 11.1 
 
Women who experienced side effects were likely to discontinue using their contraceptive method after one 
year. Among those who experienced side effects on their enrollment method, only 39 percent of those 
interviewed in the 12-month interview (n=576) were still using their enrollment method after one year, 
compared to 67 percent of the total sample (data not shown). Twenty-one percent discontinued 
contraception altogether, while 25 percent switched to a different modern method and 15 percent switched to 
traditional methods (data not shown).  
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Reasons for discontinuation of enrollment method  
Of the 2,699 women who were enrolled into the study, 5 percent were not interviewed in any of the follow-
up interviews. Because their contraceptive use is not known after the enrollment period, they were excluded 
from analyses of enrollment method discontinuation since it is not known if they discontinued the method. 
Of the 2,559 who were interviewed in at least one follow-up interview, 921 women (36%) discontinued their 
enrollment method at some point during the study duration. This includes women who switched to other 
methods at the time of discontinuation or later, and those who discontinued altogether.  
Table 5 presents women’s spontaneously reported reasons for discontinuation of the enrollment method 
(multiple responses were possible, but responses were not read out). Overall, nearly one-quarter (24%) of 
those who discontinued did so due to side effects/health concerns while one-fifth (20%) discontinued the 
method because they had not menstruated since starting to use the method. Twelve percent discontinued 
because they wanted to become pregnant and 10 percent discontinued because their husband was not living 
at home. Nearly one-quarter (24%) did not list a reason for discontinuing their enrollment method.  
Reasons for discontinuation varied by method initiated at enrollment. For PPIUD and interval IUD 
discontinuers, side effects/health concerns (34% of PPIUD users and 28% of interval IUD users) was the 
most common reason for discontinuing. Over half of injectable users who discontinued the method reported 
they had not menstruated since beginning the method (51%). OCP discontinuers stopped using the methods 
to become pregnant (20%) or because their husband was not living at home (18%). 
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TABLE 5. REASONS FOR DISCONTINUATION OF ENROLLMENT METHOD, BY 
ENROLLMENT METHOD 
 Enrollment Method  
Discontinuation reason† 
PPIUD 
(n=130) 
IUD 
(n=168) 
Injectable 
(n=313) 
OCP 
(n=310) 
Combined 
(n=921) 
Fertility-related reasons      
   Wants to become pregnant 3.8 13.1 5.4 20.3 11.6 
   Husband not living at home 12.3 7.7 3.5 18.1 10.4 
   Not having sex 3.1 4.8 3.8 1.3 3.0 
   Infrequent sex 5.4 1.2 1.3 1.6 2.0 
   Up to god/fatalistic 1.5 1.8 1.0 0.6 1.1 
   Can't get pregnant 3.1 1.8 0.0 0.3 0.9 
   Menopausal/hysterectomy 0.0 0.0 0.3 0.0 0.1 
Opposition to use      
   Husband opposed 13.1 5.4 9.6 3.2 7.2 
   Mother-in-law opposed 7.7 1.2 3.5 1.6 3.0 
   Others opposed 3.8 0.0 1.0 0.3 1.0 
   Religious prohibition 0.8 0.0 0.3 0.0 0.2 
Lack of knowledge      
   Lack of knowledge/does not know any 
other method 0.0 1.8 0.3 0.3 0.5 
   Knows no source 0.0 0.0 0.3 0.6 0.3 
Method-related reasons      
   Side effects/health concerns 33.8 28.0 24.6 17.1 24.0 
   Not menstruated since start of 
method 4.6 4.8 51.4 2.6 19.9 
   Lack of access/too far 0.0 0.0 5.4 1.3 2.3 
   Costs too much 0.0 0.0 1.6 0.0 0.5 
   Inconvenient to use 1.5 5.4 1.9 3.2 2.9 
   Interferes with body's normal 
processes 3.8 3.0 6.1 2.3 3.9 
   Wanted more effective method 2.3 4.8 0.3 3.2 2.4 
   Method failure/pregnancy 0.0 1.8 1.3 3.9 2.1 
No reason spontaneously mentioned 36.2 32.7 13.4 23.2 23.5 
†Multiple responses possible 
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Contraceptive use dynamics after 12 months  
Table 6 presents a cross-sectional look at methods used at the 12-month follow-up interview by enrollment 
method (n=2,441). The percentage of women who were using the enrollment method (highlighted in green) 
was the highest for OCP users (75 percent), followed by interval IUD users (74 percent), and PPIUD users 
(66 percent). Only 44 percent of injectable users were using the injectable after 12 months.  
Across all methods initiated at enrollment, more users switched to a modern method compared to a 
traditional method. For example, 23 percent of injectable contraceptive users at enrollment switched to a 
different modern method by the 12-month interview compared to 13 percent who switched to a traditional 
method (rhythm method, withdrawal, and abstinence; data not shown). Similarly, 16 percent of PPIUD users 
switched to another modern method by the 12-month interview while 12 percent switched to a traditional 
method. Among interval IUD users, 11 percent switched to another modern method and 5 percent to a 
traditional method, while 8 percent of OCP users switched to modern and 3 percent switched to traditional 
methods.  
PPIUD users at enrollment switched to withdrawal method (9%), condoms (8%), OCPs (5%), and female 
sterilization (3%). Interval IUD users at enrollment mainly switched to condoms (4%), OCPs (3%), and 
withdrawal (3%). Nearly one-quarter of injectable users at enrollment switched to other methods, such as 
OCPs (11%), withdrawal (10%), and condoms (7%). OCP users at enrollment switched to female sterilization 
(3%), followed by condoms (2%) and withdrawal (2%). 
Compared to other methods initiated at enrollment, injectable users were more likely to discontinue using 
contraception altogether by the 12-month interview (20%) while PPIUD users were least likely to discontinue 
using contraception by 12-months (6%).  
Additional analysis of use dynamics revealed that about five percent of OCP users at enrollment discontinued 
the method at some point in the study and then switched back to OCPs by the 12-month follow-up.  
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TABLE 6. CONTRACEPTIVE USE AT 12-MONTH INTERVIEW, BY ENROLLMENT METHOD 
 Contraceptive method used at 12-month follow-up 
Enrollment 
method IUD Injectable OCP Condom 
Female 
sterilization 
Male 
sterilization LAM 
Rhythm 
method Withdrawal Abstinence 
Not using 
any method 
PPIUD 
(n=358) 65.6 0.0 5.0 7.8 3.1 0.0 0.0 1.7 8.7 1.7 6.4 
Interval IUD 
(n=564) 73.8 0.9 3.2 4.4 2.3 0.0 0.0 0.2 2.7 2.1 10.5 
Injectable 
(n=510) 2.2 43.5 10.8 7.1 2.9 0.2 0.0 0.4 9.8 2.8 20.4 
OCP  
(n=1,009)  
1.4 0.8 75.0 2.2 3.1 0.1 0.3 0.1 1.9 1.3 13.9 
Combined 
(n=2,441) 27.7 9.6 34.7 4.5 2.9 0.1 0.1 0.4 4.7 1.8 13.4 
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Figure 7 is a Sankey diagram showing how individual women moved through various contraceptive use states 
over the one-year study period—i.e., at enrollment, and 3, 6, and 12 months later. It includes women who 
completed at least one follow-up survey (n=2,559) and excludes 140 women who were lost to follow-up at 
the 3-month interview and who never returned to the study. The diagram shows the following contraceptive 
use states of women at each time point: consistent use of the enrollment method (continued enrollment 
method), use of a different method than the method adopted at enrollment (switched methods), nonuse of 
any contraceptive method (discontinued contraception), and lost to follow-up. On the left side of the 
diagram, users of each enrollment method are presented by color, and the colors represent the enrollment 
method throughout the diagram. For example, women who adopted the PPIUD (n=376) at enrollment are 
presented in navy blue and can be followed through the study by this color.  
The percentages on the figure represent women’s contraceptive use states cross-sectionally—that is, the 
percentage of women at each time point in each state, regardless of their individual movement. At the 3-
month interview, three-quarters (75%) of women were still using their enrollment methods, and this dropped 
slightly to 69 percent at the 6-month interview. By the 12-month interview, over half of women (61%) had 
consistently used their enrollment method. Cross sectionally, the percentage of women who switched to a 
different method (including both modern and traditional methods), increased from 8 percent at 3 months to 
nearly one-quarter (22%) at the 12-month interview. This includes women who switched methods at that 
follow-up interview regardless of whether they continued to use the same method at subsequent interview(s). 
By the end of the study period, 22 percent of women had switched to a different method. This included 15 
percent who switched to a modern method and 7 percent who switched to a traditional method.  
Cross-sectionally, the percentage of women who were not using any contraceptive method at each interview 
slightly increased from 7 percent at 3 months to 10 percent at 6 months, and to 13 percent at 12 months. 
Some women who discontinued a contraceptive method by the 3- and 6-month interview returned to FP by a 
subsequent follow-up interview: 3% of women discontinued a method at 3 months and began a new episode 
of use at 6 months, and 3% of women were not using a method at 6 months but began a new episode of use 
by 12 months. The 13 percent of women who were not using a method at 12-months comprised 4 percent 
who wanted a child within the next two years and 9 percent with an unmet need for family planning (data not 
shown).2  
Figure 7 further demonstrates that although 61 percent of women continued to use the enrollment method 
consistently for one year, there is a considerable amount of movement among states: switching to other FP 
methods, consistently using the switched methods, or discontinuing contraceptive use altogether. These data 
suggest that continuous support of women with information and opportunities to switch methods is critical 
to support women’s changing desires for various methods over time. Simply offering and distributing FP 
methods at one time is not enough to meet women’s need for voluntary contraceptive use. 
  
 
2 Unmet need for family planning includes women who were not using a method but did not want to have any more 
children, wanted to wait more than two years, or did not know whether or when they wanted to have a child. 
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FIGURE 7. WOMEN’S MOVEMENT THROUGH VARIOUS CONTRACEPTIVE USE 
STATES OVER 1-YEAR STUDY PERIOD 
 
  
PP
IU
D 
n=
1,
03
2 
n=
53
1 
n=
62
0 
3-month 6-month 12-month Enrollment 
74.8% 68.6% 60.6% 
9.9% 6.4% 4.6% 
7.0% 
15.3% 
22.0% 
12.7% 9.7% 
8.3% 
IU
D 
In
je
ct
ab
le
 
OC
P 
n=
37
6 
Continued 
enrollment 
method 
Switched 
methods 
Discontinued 
contraception 
Lost to 
follow-up 
 THE EVIDENCE PROJECT | 25 
Fertility preferences at 12-month follow-up 
Figure 8 presents three pie charts of fertility preferences reported at the 12-month follow-up interview for: 1) 
modern method users (n=1,945); 2) traditional method users (n=170); and 3) non-users of any family 
planning method (n=326). Most women (64%) who were using a modern method at the 12-month interview 
did not want to have any children in the future. Seventeen percent wanted to wait more than two years to 
have a child, 3 percent wanted to have a child within one to two years, and one percent wanted to have a 
child within the next year. Fifteen percent didn’t know whether or when they wanted to have their next child.  
More than half (56%) of traditional method users did not want to have any more children at the time of the 
12-month follow-up and 14 percent wanted to wait for two years or more before having their next child. Four 
percent wanted a child within one to two years and 2 percent wanted to have a child within the next year. 
Nearly one-quarter (24%) didn’t know whether or when they wanted to have their next child. Among women 
who were not using any family planning method, 50 percent did not want to have any more children, 7 
percent wanted to wait two years or more, and 12 percent didn’t know whether or when they wanted to have 
a child, suggesting a significant level of unmet need for family planning among this group of non-users. Over 
one-quarter (26%) wanted to have a child within the next year, a much greater proportion than for modern 
and traditional method users.  
Among the 50 percent of non-users who did not want to have any more children (n=163), the main reasons 
for discontinuing their most recent method were not menstruating since beginning the method (reported by 
20%), side effects/health concerns (20%), and husband not living at home (18%) (data not shown).  
 
FIGURE 8. FERTILITY PREFERENCES AT 12-MONTH FOLLOW-UP AMONG USERS OF 
MODERN METHODS, TRADITIONAL METHODS, AND THOSE NOT USING ANY 
METHOD 
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Figure 9 shows that at the individual-level, fertility preferences change over time and do so within relatively 
short time intervals. While looking at the data cross-sectionally, it appears that fertility preferences are 
relatively stable—between 54 and 59 percent of respondents reported not wanting any more children at 
enrollment. However, when examining preferences at the individual level, preferences can vary substantially 
over a one-year period. Among the 59 percent of women who reported not wanting any more children at 
enrollment, 35 percent reported they wanted to have a child in at least one follow-up survey (data not shown). 
Similarly, while 28 percent of women reported they wanted to wait more than two years before having a child 
at enrollment, nearly all (95%) of them changed their preference in a follow-up interview. Among the 6 
percent who wanted a child within two years at enrollment, 86 percent changed their preference in at least 
one follow-up. Lastly, of the 7 percent of women who were not sure whether or when they wanted a child at 
enrollment, 87 percent changed their response in a follow-up interview. Cross-sectionally, the proportion of 
women who were unsure whether or when they wanted to have more children doubled by the end of the 
study, from 7 percent at enrollment to 15 percent at the 12-month interview. 
These data suggest that while cross-sectionally fertility intentions appear to be relatively stable over time, 
when examined at an individual level, fertility preferences fluctuate substantially. In these data, 35 percent of 
women who had wanted no more children at enrollment changed their fertility preference to wanting a child 
at some time-point during the year. This suggests that providers should be cautious about how they use this 
measure in supporting women to choose a contraceptive method, especially when counseling on female 
sterilization. Understanding the strength of women’s motivations to prevent pregnancy could improve 
providers’ counseling and support of appropriate method selection. For example, providers may ask woman 
the circumstances that would influence her to change her mind about wanting no more children. Other 
changes in fertility preferences were observed to be in an expected direction where over time women moved 
from wanting a child in over two years to wanting no more children.  
 
FIGURE 9. INDIVIDUAL WOMEN’S CHANGES IN FERTILITY PREFERENCES OVER 1-
YEAR STUDY PERIOD 
 
 
 
 
 
 
 
 
 
 
 
Within 2 
years 
More than 2 
years 
Don’t know 
No more 
children 
Lost to 
follow-up 
3-month 6-month 12-month Enrollment 
n=
1,
52
0 
n=
71
4 
n=
15
3 
n=
17
2 
59.4 53.7 57.3 
27.9 
6.0 
6.7 
16.6 
5.2 
14.7 
9.9 
14.6 
4.9 
16.9 
6.4 4.6 
14.7 
7.0 
14.7 
59.0 
 THE EVIDENCE PROJECT | 27 
Experiences using and obtaining contraceptive methods at 12 months 
Experiences with OCP use  
Source of OCPs 
Women using OCPs at 12-month follow-up (n=848) were asked where they had obtained their most recent 
packet of pills (Figure 10). The majority (86%) reported receiving the packet from a frontline health worker, 
including ASHAs and AWWs. Eight percent purchased a packet from a medical store, 3 percent received it 
from a government hospital, and 2 percent from a private doctor. Eighty-five percent did not pay anything 
for their last pill packet, while 7 percent paid between one and 29 rupees, 6 percent paid between 30 and 350 
rupees, and 2 percent didn’t know (data not shown). Most women who went to private sources paid for their 
pills, as 74 percent of those who went to a medical store paid for their last packet (and an additional 22 
percent didn’t know or remember the cost), and 95 percent of those who went to a private doctor paid for 
their pill packet. Those who obtained their packet from the public sector were less likely to pay: 10 percent of 
those who went to a government health facility and 4 percent who received it from an ASHA paid for their 
pill packet (data not shown). 
 
FIGURE 10. SOURCE OF MOST RECENT OCP PACKET AMONG OCP USERS AT 12-
MONTH FOLLOW-UP (N=848) 
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Missed doses of OCPs 
Those using OCPs at 12-months (n=848) were also asked whether they had missed any doses of the pill.3 
Seventeen percent of OCP users reported missing a dose in this period (Table 7). Women were also asked 
what they did when they realized they had missed a dose, the reason they missed a dose, and how many times 
they had missed a dose. After realizing they had missed the dose, 12 percent of pill users took two pills at 
once the next day, and 2 percent took the forgotten pill immediately upon remembering, which are the 
correct reactions to a missed dose, while 3 percent took one pill the next day. Less than one percent 
discontinued OCPs when they missed a dose. The most common reason reported for missing the dose was 
forgetting to take the pill, reported by 10 percent of OCP users, while 4 percent forgot their pill packet while 
traveling, 3 percent ran out of pills, and less than one percent reported other reasons. Of those who had 
missed a dose, most had missed more than one dose: 8 percent of pill users missed a dose twice and 6 percent 
missed a dose three or more times.  
 
TABLE 7. AMONG OCP USERS AT 12-MONTHS, THE PERCENTAGE WHO MISSED A 
DOSE AND THEIR REACTIONS, REASONS, AND NUMBER OF DOSES MISSED 
(N=848) 
 OCP users at 12-month (n=848) 
Experiences missing OCP doses % n 
Proportion that missed a dose  17.0 144 
Reaction to missed dose   
   Took two pills at once the next day 11.6 98 
   Took one pill the next day 2.9 25 
   Took a pill immediately 2.4 20 
   Discontinued OCP 0.1 1 
Reason the dose was missed   
   Forgot to take the pill 9.6 81 
   Forgot pill packet while traveling  3.9 33 
   Was out of pills 3.4 29 
   Other  0.1 1 
How many times a dose was missed   
   Once 3.2 27 
   Twice 7.7 65 
   Three or more times 6.1 52 
 
Consistency of OCP use while husband is away 
Women whose husbands occasionally lived elsewhere for work (n=265) were asked whether they took their 
doses of OCPs when their husbands were away. Seventy-three percent of these women reported that they 
took their pills regularly while their husband was away (data not shown).  
Experiences with injectable use 
Women using the injectable at the 12-month interview (n=235) were asked where they plan to receive their 
next dose of the injectable. Just over half (51%) said they would go to a government hospital, 46 percent to 
an NGO-run clinic, and 2 percent to a private doctor. 
 
3 For those who had continued using OCPs since the preceding interview, this question asked about the three months 
preceding the interview, while new OCP users since the last interview were asked this since beginning the method.  
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At their previous visit to receive the injectable method, 48 percent of injectable users at 12 months (n=235) 
did not pay for the injectable method, and 46 percent paid 200 rupees for the injection. One percent paid 
between 1 and 150 rupees, while 5 percent paid between 300 and 305 rupees (data not shown).  
Experiences with IUD use 
IUD follow-up visits 
The World Health Organization (WHO) recommends women go for a follow up 3-6 weeks after insertion, 
and then at any time to discuss side effects, problems, switching methods, or IUD removal (WHO 2016). Of 
676 women using the IUD (both PPIUD and interval IUD) at 12-month follow-up interview, just over half 
(54%) reported going for a follow-up visit after receiving the IUD and most of them (53%) went to the same 
public facility where they had the IUD inserted (Table 8). Of all IUD users, 6 percent went to a follow-up 
visit unaccompanied. Twenty-two percent were accompanied by their husband, 22 percent went with an 
ASHA, and 2 percent were accompanied by their mother-in-law. Others went to the follow-up visit with their 
mother, sister, or someone else. Just over one-quarter (27%) of IUD users went to see if everything was all 
right, 20 percent reported that the provider asked them to return, 7 percent went to the facility for child 
immunization, and one percent went to consult their provider about side effects.  
 
TABLE 8. PROPORTION OF IUD USERS WHO WENT FOR IUD FOLLOW-UP VISIT,  
LOCATION OF VISIT,  AND PERSON ACCOMPANIED TO VISIT AMONG IUD USERS AT 
12-MONTH INTERVIEW (N=676) 
 IUD users at 12-month (n=676) 
IUD follow-up visits % n 
Proportion that went for follow-up visit 54.3 367 
Location of follow-up visit   
   The same facility as insertion 53.0 358 
   A different government facility 1.2 8 
   A different private facility 0.1 1 
Person who accompanied IUD user to visit   
   Husband 22.3 151 
   ASHA 22.0 149 
   Mother-in-law 1.8 12 
   Sister-in-law 0.7 5 
   Mother 0.6 4 
   Sister 0.4 3 
   Other family member or neighbor 0.3 2 
   No one 6.1 41 
Reason for follow-up visit   
   Just wanted to see if everything was all right 26.5 179 
   Provider asked respondent to return for follow-up 20.0 135 
   Went for child immunization 6.8 46 
   Consult on side effects  1.0 7 
 
Forty-six percent of IUD users did not go for a follow-up visit after receiving the IUD. Forty-three percent 
of IUD users at 12 months said they did not go for a follow-up visit because they did not have any problems 
with their IUD. One percent did not have anyone to accompany them to the facility. Other reasons named by 
less than one percent of IUD users included not having money to go for a follow-up visit, having personal or 
family problems, or feeling afraid to go for a follow-up (data not shown).  
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IUD removal  
At 12-month follow-up interview, 13 percent of 775 IUD users discontinued using the IUD since the 
previous interview. Three percent of IUD users went to the same facility where the IUD was inserted to have 
it removed, 4 percent reported going to a different facility from where their IUD was inserted, and 3 percent 
reported the IUD was expelled on its own (data not shown).  
Experiences with female sterilization 
By the 12-month interview, 41 women had transitioned to female sterilization, including 3 percent of those 
using PPIUD at enrollment, 2 percent of interval IUD users, 3 percent of injectable users, and 3 percent of 
OCP users. Table 9 provides information about their experiences when undergoing sterilization. Forty-four 
percent of women reported their sterilization took place in a government hospital; 27 percent in a community 
health center, rural hospital, or primary health center; 15 percent went to a government dispensary; and 7 
percent went to an NGO or trust hospital.  
Sterilization users also reported on the care they received at the time of sterilization. Ninety-five percent said 
they were told they would not be able to have any more children before the procedure. Slightly less than half 
(46%) reported that the care they received during sterilization was “very good,” 51 percent reported it was 
“all right,” and one woman reported it was “not so good.” When asked if they regret having the sterilization, 
all women responded that they did not regret having the procedure.  
 
TABLE 9. DETAILS OF FEMALE STERILIZATION ADOPTION BY 12-MONTH FOLLOW-
UP INTERVIEW (N=41) 
 Sterilization users at 12-month 
(n=41) 
 % n 
Location of sterilization    
   Government hospital 43.9 18 
   CHC/rural hospital/PHC 26.8 11 
   Government dispensary 14.6 6 
   NGO or trust hospital/clinic 7.3 3 
   Private hospital 2.4 1 
   Other 4.9 2 
Respondent was told she would not be able to have additional children   
   Yes 95.1 39 
   No 4.9 2 
Respondent’s rating of care received during procedure   
   Very good 46.3 19 
   All right 51.2 21 
   Not so good 2.4 1 
Respondent regrets having female sterilization   
   No 100 41 
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Experiences of pregnancy during 12-month study period 
At each follow-up interview, women were asked whether they had experienced a pregnancy in the preceding 
three months. Table 10 presents the proportion of women who reported experiencing a pregnancy at some 
point during the study, among all women who were interviewed in at least one follow-up interview (n=2,559). 
These proportions are not contraceptive failure rates, as some women had stopped using their contraceptive 
method prior to experiencing pregnancy. Overall, 7 percent reported experiencing a pregnancy during the 
study. Ten percent of OCP users, 8 percent of injectable users, 5 percent of interval IUD users, and 2 percent 
of PPIUD users at enrollment experienced a pregnancy.  
 
TABLE 10. EXPERIENCE OF PREGNANCY DURING THE 12-MONTH STUDY PERIOD, 
BY ENROLLMENT METHOD  
 Experienced a pregnancy at some point during the study 
Enrollment method* % n 
PPIUD (n=376) 2.4 9 
Interval IUD (n=620) 5.6 35 
Injectable (n=531) 7.7 41 
OCP (n=1,032) 9.5 98 
Combined (n=2,559) 7.2 183 
* p<0.05 
Clients who experienced a pregnancy during the study period (n=183) were also asked about the intendedness 
of that pregnancy: whether the pregnancy was wanted then, wanted later, or not wanted at all (Table 11). 
Intendedness of the pregnancy was asked of women when the pregnancy was first reported. Slightly less than 
half (49%) of women who experienced a pregnancy wanted their pregnancy at the time they became 
pregnant, while 24 percent wanted to become pregnant at a later time. Just over one-quarter (27%) did not 
want to become pregnant at all, and one percent didn’t know.  
 
TABLE 11. INTENDEDNESS OF PREGNANCY WHEN FIRST REPORTED, AMONG 
WOMEN WHO EXPERIENCED A PREGNANCY DURING THE STUDY PERIOD, BY 
ENROLLMENT METHOD 
 Intendedness of pregnancy when first reported 
Enrollment method Wanted then  Wanted later  Not wanted at all  Don't know  
PPIUD (n=9) 66.7 11.1 22.2 0.0 
IUD (n=35) 60.0 17.1 22.9 0.0 
Injectable (n=41) 34.1 19.5 43.9 2.4 
OCP (n=98) 50.0 28.6 20.4 1.0 
Combined (n=183) 49.2 23.5 26.2 1.1 
 
Of those who reported wanting their pregnancy at the time they became pregnant, 64 percent reported that 
they had discontinued their enrollment method due to a desire to become pregnant, while others 
discontinued due to side effects (11%), lack of menstruation (6%), inconvenience (2%), husband not living at 
home (2%), husband opposition (1%), mother-in-law opposition (1%), or did not list a reason (18%) 
(multiple responses possible, data not shown). On the other hand, 23 percent of those who wanted their 
pregnancy later and 17 percent of those who did not want their pregnancy at all reported discontinuing their 
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enrollment method due to method failure. However, 37 percent of those who reported they wanted their 
pregnancy at a later time also reported that they discontinued because they wanted to become pregnant, while 
this was a reason for only 7 percent of those who reported they did not want to become pregnant at all. Side 
effects/health concerns was a reason for discontinuation listed by 10 percent of those who wanted to become 
pregnant later and 24 percent of those who did not want to become pregnant at all, suggesting that these 
women would have been potential candidates for method switching.  
Women who reported experiencing a pregnancy during the study also reported whether that pregnancy ended 
in termination or miscarriage. Of the 183 pregnancies reported during the study period, six ended in 
miscarriage and 25 ended in termination. Eight women used a pill to terminate the pregnancy, while 17 
reported termination by a cleaning done by a doctor or nurse (data not shown).  
Strengths and limitations of the study 
This study has collected longitudinal data on modern reversible contraceptive users in India, a largely 
understudied group, but a group that is a focus of India’s FP2020 commitment. One of the most significant 
strengths of this study was that it was conducted prospectively, so that the effect of recall bias on responses 
was reduced considerably compared to retrospective studies. 
One limitation of the study is that timing and strategies for enrollment into the study varied by state and 
family planning method. Women in Haryana were enrolled into the study via ASHAs and enrollment began 
several months after it began in Odisha, where enrollment occurred at government facilities, at NGO 
facilities, and through ASHAs.  
Additionally, enrollment of injectable users was challenging, and the desired sample size was not met, as the 
study began just before the method was rolled out in the public sector. However, these findings can be useful 
for the Government of India in planning how to allocate future resources for injectable use. 
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Discussion 
The purpose of this longitudinal study was to assess the dynamics of reversible contraceptive use over the 
course of one year, including contraceptive choice, discontinuation, and switching behaviors, as well as quality 
of care and experience of side effects. A total of 2,699 married women of reproductive age (15-49 years) from 
Odisha and Haryana states were enrolled into the study, including 420 PPIUD users, 640 interval IUD users, 
581 injectable users, and 1,066 OCP users. As respondents were purposively sampled, estimates are not 
representative of contraceptive users at the state level nor of all method-specific users. However, these data 
can provide valuable insights for understanding the experiences of reversible contraceptive users, which is 
critical in India as the government aims to expand access to and use of reversible contraceptives in its 
national family planning program.  
In the enrollment interview, women were asked about the quality of care they received from the provider or 
frontline health worker who provided them with or counseled them about their method. While there were 
some aspects of quality of care that the majority of women across all methods received, such as being treated 
well (99-100%) or being told how the chosen method works (ranging from 66 percent of PPIUD users to 91 
percent of OCP users), there is room for improvement in quality, because 100 percent of women should be 
reporting receiving quality of care across the four domains: respectful care, method selection, effective use of 
method selected, and continuity of contraceptive use and care. Though this study did not observe client-
provider interactions, clients’ reported quality received provides insights into what information they were 
walking away with after interacting with providers. Additionally, while responses about process quality 
received may be subject to recall bias, this is likely to be minimal because the enrollment interview occurred 
within 30 days of a woman receiving her family planning method.  
There were differences in quality received by method and other respondent characteristics. For instance, 
PPIUD users consistently reported receiving lower levels of quality of care compared to users of other 
methods. PPIUD users may have received counseling and information from providers or frontline health 
workers during antenatal care visits, but the information exchange between provider and client should be 
reiterated at the time of insertion, even if counseling had occurred prior. Additionally, the differences in 
receipt of the MIIplus by wealth tertile and urban/rural residence suggest that there is a need to ensure that 
all women receive high quality care, regardless of their financial means and where they live.  
Implications: Quality of care should be improved for users of all modern methods of family 
planning, and especially for PPIUD users and women of lower wealth status. Quality of care 
improvement efforts should also be routinely monitored and tracked to ensure that women are 
receiving high quality services. Providers of all cadres should be trained on respectful care, and 
information exchange on appropriate method selection, effective use of methods, and continuity 
of contraceptive use and care. 
At each follow-up interview, women were asked whether they had experienced side effects of their family 
planning method. Just 23 percent of women had experienced at least one side effect while using their 
enrollment method throughout the course of the study, though this varied widely by method. Half of 
injectable users (50%) experienced a side effect while using the method, while this was true for 22 percent of 
PPIUD users, 22 percent of IUD users, and 11 percent of OCP users. The most common side effects were 
heavy bleeding (reported by 6% of women), abdominal pain (6%), and lack of menstruation (6%). Less than 
one in five women (18%) talked to someone about side effects, and only 12 percent spoke to a provider or 
health worker about the side effects, suggesting women who have recently begun using a contraceptive 
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method are not always seeking follow-up care or being visited by frontline health workers. Injectable users 
were the most likely to experience side effects, and also the most likely to discontinue their method over the 
course of the study. As the injectable is a relatively new method available in public health facilities in India, 
understanding that half of injectable users experienced side effects and most discontinued the method is 
valuable information for the Indian government to use in efforts to make the method more widely available 
across the country. Before starting the method, women who receive the injectable should be adequately 
counseled on side effects of the method, what to do if they experience side effects, and what methods they 
could switch to if the side effects of the injectable make it an unsuitable method.  
Women’s reasons for discontinuation of the enrollment method shed additional light on their contraceptive 
use dynamics. Among women who discontinued the enrollment method at some point during the study 
(n=921), reasons for discontinuation were primarily related to the method used: the most commonly cited 
reason was side effects/health concerns (24%). Twenty percent discontinued due to not menstruating since 
starting the method, and this was the most common reason among injectable users. Given this large 
proportion of discontinuation due to side effects and changes in menstruation, it is critical that providers 
discuss potential side effects of available methods, how they might impact women’s lives, and any other 
health concerns a woman has before she adopts a method. Modern fertility-awareness based methods may be 
a suitable alternative for women who want to prevent pregnancy but find these side effects unacceptable, and 
should be included in counseling on method selection. Other women discontinued for fertility-related 
reasons: 12 percent of discontinuers wanted to become pregnant and 10 percent reported their husband was 
not living at home, and these proportions were greater among OCP users. These women did not have an 
immediate need for family planning and discontinued their method according to their fertility preferences and 
needs. 
Implications: Most women (77%) did not report experiencing side effects on their enrollment 
method, though many who discontinued the enrollment method did so due to side effects or other 
health concerns. Contraceptive initiators should receive follow-up visits from frontline health 
workers to provide support and answer questions related to the method selected. These visits 
could assist women with information on managing side effects or switching to a different method. 
While most women—61 percent—continued to use the method they adopted at enrollment throughout the 
year, considerable movement among contraceptive use states was observed, including switching to different 
FP methods, continuing use of the switched methods, or discontinuing contraceptive use altogether. These 
findings highlight the importance of providers and ASHAs offering continuous support to women who want 
to delay or prevent pregnancy that includes opportunities to switch methods as their fertility desires change 
over time. Information and FP methods offered to women at the initial FP visit alone is not enough to ensure 
that women continuously meet their needs for voluntary contraceptive use; continuous follow-up is needed. 
Interval IUD (74%) and OCP (75%) users were most likely to continue to use these methods they began at 
enrollment, followed by PPIUD users (66%). Less than half (44%) of injectable users continued to use 
injectables. While many of those who initiated the injectable at enrollment went on to switch to a different 
modern method by 12 months (23%), one-third (33%) discontinued modern contraception altogether. 
Compared to other methods, injectable users tended to be older in age, had more living children, were more 
likely to have used a modern method previously, and were more likely to want to stop childbearing all 
together at enrollment. Sixty-eight percent of those who initiated injectables at enrollment, but discontinued 
contraception altogether did not want to have any more children at 12 months, suggesting that these 
injectable discontinuers are potential good candidates for receiving information and support to switch to a 
different modern method.  
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The importance of ensuring women are provided with information about contraceptive switching is 
underlined by the high level of unmet need among women who discontinued using contraception after one 
year. Overall, discontinuation of all contraception was low, at 13 percent. However, less than one-third of 
those not using any method after one year wanted to get pregnant in the next two years (31%). Half of those 
not using any method did not want to have any more children in the future, 7 percent wanted to wait more 
than two years, and 12 percent didn’t know. These women, a total of 69 percent of non-users, therefore had 
an unmet need for contraception at the end of one year and may benefit from information and support to 
enable switching to a different modern method of contraception.  
Implications: Discontinuation of contraceptive use altogether after one year was relatively low. 
There was considerable movement between various states of contraceptive use. Women did 
switch to other methods, both modern as well as traditional methods. Among those who were not 
using at 12 months, however, the majority had an unmet need for family planning. At the time of 
method adoption and after the initial visit, it is important to continue to offer women information 
about the possibility of switching to other methods, including modern fertility awareness-based 
methods.  
At enrollment, most women wanted to use their family planning method for limiting (59%) or delaying 
childbearing for at least two years (28%). While these preferences appeared to be relatively stable over time, 
there were substantial variations in fertility preferences over the course of the study at the individual level. For 
example, when examining the data longitudinally, over one-third (35%) of women who did not want to have 
any children at enrollment changed their mind and reported wanting to have more children in at least one 
follow-up interview. This was even higher for women who reported wanting a child within two years (86% 
changed their mind), in more than two years (95% changed their mind), or didn’t know (87% changed their 
mind). Additionally, a significant proportion didn’t know whether or when they wanted to have another child 
in at least one interview, as 6 percent of respondents at enrollment and 15 percent after one year were unsure. 
Being unsure of fertility preferences is a legitimate response that may change over time, and providers and 
ASHAs should be sure to ask women about their fertility preferences at each interaction. 
When asking women about their fertility desires, a better understanding of their motivations to prevent 
pregnancy and under what circumstances they may change their mind may help providers support women in 
selecting appropriate methods. Particularly in India, where 75 percent of family planning users use female 
sterilization, a deeper understanding of fertility desires and motivations may help to prevent sterilization 
regret, which has been reported by seven percent of women who have undergone the procedure (Singh 
2018).  
Implications: These data show that while fertility intentions appear to remain relatively 
consistent over a year, women’s desires can and do change. Asking women about their fertility 
intentions and motivation to prevent pregnancy routinely in FP counseling can help ensure that 
women are selecting methods that best meet their changing reproductive needs.  
After one year, 62 percent of respondents did not want to have any more children. While those using modern 
methods after one year were most likely to report not wanting to have any more children (64%), over half of 
those using traditional methods (56%) and half of those not using any method (50%) did not want any more 
children either. Women using traditional methods or not using family planning at all would be potential 
candidates for modern methods of contraception, including modern fertility awareness-based methods, and 
should be supported in switching to a different modern method if that would better meet their contraceptive 
needs. Since such a large proportion of modern, traditional, and non-users of family planning desired no 
more children, and since this was the strongest fertility preference among this sample of women, there is a 
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rationale to continue supporting the female sterilization program in India. Coupled with counseling about 
fertility preferences and motivation to prevent pregnancy, this could help enable women in India with an 
unmet need for limiting to meet their reproductive intentions.  
Implications: India should continue to expand the basket of methods available to women while 
supporting sterilization as part of the national family planning program. 
Seven percent of women, including both those who were using and not using a method at the time of follow-
up, experienced a pregnancy at some point during the study. (This study did not calculate failure rates of 
contraceptive methods.) Of the 183 women who experienced a pregnancy during the study period, half (51%) 
did not want to become pregnant at all, did not want to become pregnant at that time, or didn’t know. This 
underscores the importance of enabling women to continue using modern contraception that fits their 
reproductive needs. Less than 10 percent of women who experienced a pregnancy terminated the pregnancy. 
Implications: As half of pregnancies experienced in this study were not wanted at all or at that 
time, there is a need to ensure that women are offered an array of methods to switch to in order to 
prevent unwanted pregnancies.   
 THE EVIDENCE PROJECT | 37 
References 
Family Planning 2020 and Government of India. 2017. Family Planning 2020 Commitment. London, UK. 
International Institute for Population Sciences (IIPS). 1995. National Family Health Survey (MCH and Family 
Planning), India 1992-93. Bombay: IIPS. 
International Institute for Population Sciences (IIPS) and ICF. 2017. National Family Health Survey (NFHS-
4), 2015-16. Mumbai, India: IIPS. 
Jain, Anrudh K., John Townsend, and Saumya RamaRao. 2018. Proposed metrics to measure quality: An 
overview. Working Paper no. 3, prepared for the Measuring and Monitoring Quality of Care Project. New 
York: Population Council. 
Jain, Aparna, Kumudha Aruldas, Arupendra Mozumdar, Elizabeth Tobey, and Rajib Acharya. 2019a. 
Validation of Two Quality of Care Measures: Results from a Longitudinal Study of Reversible Contraceptive 
Users in India. Studies in Family Planning, 50(2): 179-193. 
Jain, Aparna, Kumudha Aruldas, Elizabeth Tobey, Arupendra Mozumdar, and Rajib Acharya. 2019b. Adding 
a question about method switching to the Method Information Index is a better predictor of contraceptive 
continuation. Global Health Science and Practice, 7(2): 289-299. 
Scott, Kerry, Dena Javadi, and Jessica Gergen. 2014. India’s Auxiliary Nurse-Midwife, Anganwadi Worker, 
Accredited Social Health Activist, Multipurpose Worker, and Lady Health Visitor Programs. Boston, 
Massachusetts: Initiatives, Inc., CHW Central. 
Singh, Abhishek. 2018. Sterilization Regret Among Married Women in India: Trends, Patterns and Correlates. 
International Perspectives on Sexual and Reproductive Health, 44(4): 167-176. 
World Health Organization (WHO). 2016. Selected practice recommendations for contraceptive use: Third 
edition 2016. Geneva: WHO.  
  
 38 | RESEARCH REPORT 
 
 
 
The Evidence Project 
Population Council 
4301 Connecticut Avenue, NW, Suite 280 
Washington, DC 20008 USA 
tel +1 202 237 9400 
 
evidenceproject.popcouncil.org  
 
The Evidence Project 
Population Council 
4301 Connecticut Avenue, NW, Suite 280 
Washington, DC 20008 USA 
     
 
  
